AUTHOR INDEX Acchiardo, S., 74 Adams, P., 116 Bennett, S.E., 125 Beto, J.A., 1,55, 84, 98, 115, 161 Cockram, D.B., 88 DeTar, S.J., 182 Edmunds, M.E., 125 Fedje, L., 144 Feehally, J., 125 Fischer, D.R., 130 Foulks, C.J., 23,119 Gallagher, C.M., 98,146,189 Goldstein, D.J., 9, 23 Hanrahan, K.E., 134 Hensley, M.K., 84, 187 Hunt, J.M., 23 Hunt-Fugate, A, 140 Ostergren, C., 144 Pagenkemper, J.J., 119 Patel, C., 41,182 Jones, M.F., 130 Jones, W.O., 80 Reams, S., 188 Kelly, M.P., 23 Komaransky, Z.A., 134 Makoff, R., 56 McCann, L., 94 Mitchell, C.O., 74 Moore, L.w., 74, 88 Muth, I.E., 2 Nelson, E.E., 162 Nemec, A, 134 Nidus, B.D., 80 Schmitt, J., 38,197 Smith, S.O., 74 Soinski, J., 134 Striegel, M.E., 34 Strom, J.A., 9 Valdin, J., 182 Walls, J., 125 Wilson, B.M., 173 American Dietetic Association Renal Practice Group annual meetings, 100 educational stipends and grants, 99 publications, 100 purposes and goals, 99 v Council on Renal Nutrition, 98-100 American Society of Nephrology diet/nutrition focus at 1990 meeting, 55 Amino acid(s) dietary inhibiting vitamin B'2 and folic acid, Anemia recombinant human erythropoietin therapy for, 125- Anthropometry application of in ESRD population, 170 circumference measurements, 165 current body weight assessment, 164 determining desirable body weight, 163, 164 dialysis patient measurements v published norms, 166-169 evaluating body composition, 164, 165 height and weight measurements, 162-164 interpretation of measurements, 166 limitations of, 169 nutritional assessment in end-stage renal disease, 162-172 skinfold measurements, 165 special considerations for dialysis patients, 165, 166 Ascorbic acid biologic action, 67 clinical studies of in dialysis patients, 68-70 deficiency, 67, 68 oxalosis and, 68-70 Assessment, nutrition, see Nutrition assessment Bvitamins cobalamin (B,2) status in dialysis patients, 65, 66 pyridoxine (B6) status in dialysis patients, 66, 67 riboflavin (B2) status in dialysis patients, 61, 62 role in intermediary metabolism, 56, 57 thiamin (B,) status in dialysis patients, 60, 61 Benefits, employment survey of Maryland renal dietitians, 34-37 Bioelectrical impedance 164 Biotin and hiccups in chronic dialysis patients, 80-83, 197 biologic action, 62 clinical studies of in dialysis patients, 62 deficiency, 62 Body composition anthropometric assessment in ESRD, 164, 165 bioelectrical impedance assessment, 164 computerized axial tomography assessment, 164 infrared interactance assessment, 164, 165, 170 Bone G1 a-protein, see Osteocalcin Bone status osteocalcin and, 189 Bowel function pharmacologic maintenance of in hemodialysis, Calcitriol intravenous administration in outpatient dialysis, 182-186 Calcium effect of tailoring phosphate binder doses on, Calcium carbonate role of osteocalcin in therapy with, 189 206 Journal of Renal Nutrition, Vol 1, No 4 (October), 1991: pp 206-210
Chronic renal failure, see Renal failure, chronic Circumference measurements anthropometric in ESRD patients, 165 Cobalamin biologic action, 65 clinical studies of in dialysis patients, 65, 66 deficiency, 65 drugs/toxins/amino acids inhibiting uptake/usage, Cognitive level, patient concrete v formal operation stage, 174, 175 guidelines for teaching fluid restriction based on, 179-181 matching instruction on fluid restriction to, 173-181 Computerized axial tomography 164 Computers computer-generated nutrition assessment form, Constipation pharmacologic management in hemodialysis patients, Continuous ambulatory peritoneal dialysis (CAPO) hypervitaminosis A and, 5, 6 Council on Renal Nutrition 1990 Annual Meeting Abstracts, A 1-A4 (Jan) 1991 Annual Meeting Abstracts, 206-210 annual meetings, 100 educational stipends and grants, 99 evolution of Journal of Renal Nutrition, 1 publications, 100 purposes and goals, 98 rules and regulations changes, 109 v American Dietetic Association Renal Practice Group, 98-100 Cyclosporine effects on nutrition in renal transplant patients, 122 Diabetic patient(s) hypervitaminosis A in CAPO treatment, 4, 5 Dialysis anthropometric measurements of patients, 165, 166 biotin and hiccups in chronic, 80-83 hemodialysis and hypervitaminosis A, 4, 5 hypervitaminosis A in CAPO, 5, 6 intravenous calcitriol in outpatient setting, 182-186 patients' anthropometric measurements v norms, 166-169 see also Hemodialysis and Peritoneal dialysis vitamin loss during, 58 water-soluble vitamin status during peritoneal, 56-73 Diarrhea pharmacologic management in hemodialysis patients, Diet(s), renal prescription empathy in educating patients about, 161 in India, 41, 42 207 Diet(s), renal prescription (Continued) in Japan, 86, 87 see also specific dietary components Dietitian(s), renal role in outpatient IV calcitriol administration, 182-186 salary and benefits in Maryland study, 34-37 Drug(s) affecting vitamin 8'2 and folic acid uptake/usage, cyclosporine and nutrition in transplant patients, 122 effect on vitamin status in dialysis patients, 57- laxative agents for hemodialysis patients, 141 Drug-nutrient interactions in computer-generated nutrition assessment form, Education, of patients, see Patient education End-stage renal disease (ESRD) anthropometry in nutritional assessment of, 162-172 application of anthropometry in, 170 causes of vitamin derangements in, 57, 58 intradialytic parenteral nutrition in, 23-33 Energy metabolism in adult renal transplant patients, 121 Erythropoietin, recombinant human nutritional status of hemodialysis patients on, 125- Fiber, dietary bowel function in hemodialysis patients and, 132, 133 Fluid restriction conversion of fluid units, 188 foods counted as fluids, 188 guidelines for teaching based on learning ability, 179-181 matching instruction to patient learning ability, 173-181 patient information form for, 188 Folic acid biologic action, 63 clinical studies of in dialysis patients, 64, 65 deficiency, 63, 64 drugs/toxins/amino acids affecting uptake/ usage, Glucose metabolism in adult renal transplant patients, 122 Health care role of humor in, 115, 116-118 Height, patient anthropometry in ESRD nutrition assessment, 162, 163 Hemodialysis bowel function in patients on, 130-133 computer-generated nutrition assessment form for,
208 Hemodialysis (Continued) daily water-soluble vitamin recommendations for, 71 effect of tailoring phosphate binder doses in, history of nutritional interventions in, 23-28 hypervitaminosis A and, 4, 5 intradialytic parenteral nutrition and, 23-33 malnutrition in patients on, 23-33 pharmacologic maintenance of bowel function in, recombinant human erythropoietin therapy and, 125- water-soluble vitamin status in patients on, 56-73 Hiccups, "malignant" and biotin in chronic dialysis patients, 80-83 case report of treatment, 197 treatment for, 81 Humor bibliography of health and, 146 role of in health care, 115, 116-118 Hypercalcemia role of osteocalcin in identifying, 189 Hyperlipidemia in adult renal transplant patients, 121, 122 Hyperphosphatemia selecting appropriate phosphate binders, 38-40 Hypervitaminosis A clinical signs, 3 implications in chronic renal failure, 2-8 in different treatment modalities, 4-6 India, renal nutrition in glossary of food terms, 42 sample renal meal pattern for, 41, 42 Information forms for patients, see Patient information forms Infrared interactance 164,165,170 Intradialytic parenteral nutrition administration and monitoring sheet, 19 clinical indices for patient selection, 12 clinical indices for patient monitoring, 12 estimated dry weight flow sheet, 15 evolution and current concepts, 9-22 historical review, 9-11 indications for initiating and terminating, 12-15 initiation order sheet, 18 methods of administration, 16 nutrition assessment, 13 orders for, 18 patient selection criteria, 12 problems, 1 7-19 questions on, 20 recommendations for use in hemodialysis patients, 31,32 solution prescriptions and compositions, 16 treatment monitoring, 16, 17 use in malnourished hemodialysis patient, 23-33 Japan, renal nutrition in dietetic education in, 85 International Congress of Nephrology meeting, 84 patient renal diet education, 86 renal diet composition, 86, 87 renal treatment in, 85, 86 Journal of Renal Nutrition evolution of, 1 Kinetic modeling in computer-generated nutrition assessment form, Lambda-carboxyglutamic acid, see Osteocalcin Laxative agents for hemodialysis patients, 141 Literature reviews dialysis and transplantation, 46-50, 105-109, 150-154,192-196 nutritional considerations, 45, 46, 103-105, 149, 150,191,192 social and psychological considerations, 50, 109, 154,155,196 Malnutrition intradialytic parenteral nutrition in hemodialysis, 23-33 Maryland Council on Renal Nutrition renal dietitian salary and benefits study, 34-37 Meat estimated portions of protein for dialysis patient, 96,97 Metabolism problems in adult renal transplant patients, 119-124 Mineral(s) metabolism in adult renal transplant patients, 122, 123 National Kidney Foundation diet/nutrition focus at 1990 meeting, 55 role in evolution of Journal of Renal Nutrition, 1 see also Council on Renal Nutrition Niacin biologic action, 62, 63 clinical studies of in dialysis patients, 63 deficiency, 63 Nutrition assessment anthropometry in end-stage renal disease, 162-172 computer-generated form for, Nutrition assessment form, computer-generated anthropometric data, 135, 136 development and use of, drug-nutrient interactions, 135-137 kinetic modeling, 137, 138 laboratory data summary, 137 nutritional diagnostic statements, 138 patient and treatment information, 135 Osteocalcin as indicator of renal osteodystrophy, 189 role of in calcium carbonate therapy, 189
Osteodystrophy, renal intravenous calc it rio I in outpatient dialysis, 182-186 osteocalcin as indicator of, 189 Oxalosis oxalic acid formation of, 69 vitamin C supplementation in dialysis patients, 68-70 Pantothenic acid biologic action, 62 clinical studies of in dialysis patients, 62 deficiency, 62 Parathyroid hormone suppression effect of outpatient intravenous calcitriol on, 182-186 Parenteral nutrition current concepts of intradialytic, 9-22 evolution of intradialytic, 9-22 see also Intradialytic parenteral nutrition Patient education daily protein needs, 96, 97 effect of tailoring phosphate binder doses, empathy in dietary instruction, 161 fluid control helpful hints, 188 fluid restriction instructional methods, 173-181 high- and low-potassium foods, 144, 145 matching instructional methods to learning ability, 173-181 patient compliance with phosphate binder therapy, 78 Piaget's cognitive levels, 174, 179 Patient information forms fluid control helpful hints, 188 potassium, 144, 145 protein, 96, 97 Peritoneal dialysis daily water-soluble vitamin recommendations for, 71 see also Continuous ambulatory peritoneal dialysis water-soluble vitamin status in patients on, 56-73 Phosphate binders aluminum compounds, 39 calcium compounds, 39 osteocalcin role in calcium carbonate therapy, 189 selecting appropriate, 38-40 tailoring doses in chronic hemodialysis patients, Phosphorus bowel function in dialysis patients and, 132, 133 effect of tailoring phosphate binder doses on, Potassium bowel function in hemodialysis patients and, 132, 133 high- and low-potassium foods, 144, 145 Prealbumin serum values in hemodialysis v transplant, 5 Predialysis patient(s) new nutritional supplement for, 88-93 Product updates Baxter low-protein entrees, 101 Biocare nutritional supplement drink mix, 43 209 Product updates (Continued) Dole products, 44 Entenmann's fat-free, cholesterol-free bakery products, 101, 102 frozen yogurt, 190 Healthy Choice dinners, 148 Kraft fat-free products, 102 Med-Oiet low-protein gravies and sauces, 148 Quench Mist and Quench Gum, 43 Renal Meals gourmet sauces, 147 salt substitutes, 190 Simple Pleasures, 43 Vitamite, 147 Protein metabolism in adult renal transplant patients, 120, 121 patient information form for daily needs, 96, 97 Pyridoxine biologic action, 66 causes of deficiency in dialysis patients, 60 clinical studies of in dialysis patients, 66, 67 deficiency, 66 Recombinant human erythropoietin, see Erythropoietin, recombinant human Renal dietitian(s), see Oietitian(s), renal Renal failure, chronic altered food intake in, 57 effect of water-soluble vitamin status, 57, 58 hypervitaminosis A in, 2-8 multivitamin supplementation in, 4-8 new nutritional supplement for, 88-93 recombinant human erythropoietin therapy for, 125- serum retinol and RBP in treatment modalities, 5 Retinol serum values in chronic renal failure treatment, 5 Retinol binding protein role in hypervitaminosis A development, 4 serum values in chronic renal failure treatment, 5 Riboflavin biologic action, 61 clinical studies of in dialysis patients, 61, 62 deficiency, 61 Salary survey of Maryland renal dietitians, 34-37 Skinfold measurements anthropometric in ESRO patients, 165 Standing orders use of for renal patients, 187 Thiamin biologic action, 60, 61 clinical studies of in dialysis patients, 61 deficiency, 61 Transferrin serum values in hemodialysis v transplant, 5 Transplant patient(s), renal cyclosporine effects on nutrition in, 122 energy metabolism in, 121 glucose metabolism in, 122 hyperlipidemia in, 121, 122
210 Transplant patient(s), renal (Continued) hypervitaminosis A and, 4, 5 mineral metabolism in, 122, 123 nutritional management of adult, 119-124 overview of nutritional considerations, 120 protein metabolism in, 120, 121 recommended postoperative diet, 122 Units traditional v SI, 98 Vitamin A chronic renal failure and, 3-7 hypervitaminosis A in chronic renal failure, 2-8 normal absorption and metabolism, 2, 3 status by chronic renal failure treatment modality, 4-6 Vitamin B " see Thiamin Vitamin B,2, see Cobalamin Vitamin B 2, see Riboflavin Vitamin B 6, see Pyridoxine Vitamin C, see Ascorbic acid Vitamin supplement(s) assessment for in dialysis patients, 58-60 available products, 95 calculated vitamin content for dialysis patients, 58 daily recommendations for dialysis patients, 71 Vitamin supplement(s) (Continued) drug-nutrient interactions, 57- impact of new nutritional supplement, 88-93 oxalosis and vitamin C excess, 68-70 selecting an appropriate, 94, 95 Vitamin(s), water-soluble ascorbic acid (vitamin C), 67-70 biotin, 62 cobalamin (B'2)' 65, 66 daily supplements for dialysis patients, 71 folic acid, 63, 64 malignant hiccups and biotin, 80-83 niacin, 62, 63 pantothenic acid, 62 pyridoxine (B 6 ), 66, 67 riboflavin (B 2 ), 61,62 status in patients on dialysis treatment, 56-73 thiamin (B,), 60, 61 Water-soluble vitamin(s), see Vitamin(s), watersoluble Weight, patient anthropometry in ESRD nutrition assessment, 162, 163